HOUSTON, TX / ACCESSWIRE / June 6, 2024 / LASIK eye surgeon and Ophthalmology Residency Program Director of the San…
Patent covers the Composition of the Company's Proprietary Linea™ RNAP, a Core Technology Empowering the Linea™ IVT PlatformPatent Application Also…
Roadmap to Cures is an initiative that seeks to raise $40M over the next four years to advance genetic medicine…
DNA vaccine proof-of-concept study expected to demonstrate an “mRNA better” platform LAWRENCEVILLE, N.J., June 05, 2024 (GLOBE NEWSWIRE) -- IMUNON,…
MELBOURNE, Australia, June 05, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader…
-- Poster highlights promising preclinical profile of ABI-6250 ahead of entry into the clinic, expected by end of 2024 --…
PALO ALTO, CA / ACCESSWIRE / June 5, 2024 / Bioz, Inc., an innovative AI software company based in Silicon…
The new proprietary cell line development platform combines a robust cell line, transposon technology with high throughput clone screening and…
Thought Leaders Barbara Nosal, PhD, LMFT, LADC, and Don Grant, PhD, MA, MFA, DAC, SUDCC IV, to Address the Impact…
SAN DIEGO, June 4, 2024 /PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies,…